Mucorex DX Syrup 60 ml


Each 5 ml contains:
Dextromethorphan HBr        –    10 mg
Cetirizine       –      5 mg
Phenylephrine HCl   –    5 mg
Menthol    –    1.5 mg


60ml syrup

Product Description

Mucorex DX syrup contains dextromethorphan hydrobromide, cetirizine and phenylephrine hydrochloride and menthol.

Dextromethorphan hydrobromide belongs to morphine class of drug. It is cough suppressant or anti-tussive drug which possesses sedative and dissociative properties.

Cetirizine is a second generation antihistamine. It is mainly used for the treatment of hay fever, angioedema or urticaria.

Phenylephrine hydrochloride is a direct acting sympathomimetic agent.

Menthol is an organic compound which is obtained from cornmint or mint oil. It is a local anesthetic used to relieve minor throat irritation.

  • Common cold or flu
  • Breathing illnesses (such as sinusitis, bronchitis)
  • Help in relief in watery eyes, itchy eyes/nose/throat
  • Allergies
  • Rhinovirus infection
  • Kimura’s diseases
  • Chronic urticaria
Mechanism of action

Phenylephrine is a powerful vasoconstrictor and produces local and systematic action on by acting on α1-adrenergic receptors peripheral vascular smooth muscle.


It competes with histamine for binding at H1 receptor on the effectors cell surface which causes the suppression histaminic edema and pruritus. The low incidence of sedation is because the reduced penetration of cetirizine into CNS.


It is well absorbed in the body with mean peak plasma concentration (Cmax) of 114 ng/mL at a time (Tmax) of 2.2 hours
It is well distributed in the body with 93% plasma protein binding. Vd is 0.41kg
The plasma half life is 7.9 ± 1.9 hours; total body clearance is 0.63 ml/min/kg
It is absorbed after oral administration with reduced bioavailability about 38%. It follows first pass metabolism with peak serum concentration of 0.75-2 hours.
The protein binding of the drug is about 95%
Phenylephrine and its metabolites are excreted in urine
After administration it gets well absorbed in the body from gastrointestinal tract and it exerts pharmacological effects in 15-30 minutes. The duration of action is 3-6 hrs.
It is metabolized primarily by liver enzyme undergoing O-demethylation, N- demethylation, and partial conjugation with glucuronic acid and sulfate.
The unmetabolised drug is excreted in urine.

  • Patients with hypersensitivity to such drugs
  • Renal disease
  • Pediatric patients with renal impairment
  • Hypersensitivity to any of the product
  • Patients with hypersensitivity to such drugs
  • Patients with predisposing factors of urinary retention
  • Long treatment can cause somnolence, fatigue, and asthenia
  • Patient should not involved in those task which require complete concentration
  • Patients with predisposing factors of urinary retention
  • Dextromethorphan should not be used in pediatric patients
  • Dextromethorphan should be cautiously used in the patients with bone marrow depression.